The global cell counting market size is expected to reach USD 15.46 billion in 2030 and is projected to grow at a CAGR of 8.7% from 2025 to 2030. Rising prevalence of chronic diseases such as cancer, HIV, and Alzheimer’s is the high impact rendering growth driver of the industry. Increasing prevalence of these diseases has surged clinical research activities, consequently propelling the demand for cell counting instruments and consumables. Government initiatives working to promote the development of cell therapeutics, wherein cell counting plays an imperative role, are also expanding growth prospects for the market.
An
increase in the number of collaborations of research institutes with various
public and private entities to promote R&D has provided a significant boost
to growth. Growing number of proposed guidelines and recommendations for public
and private laboratories to ensure high-quality standards and facilitate the
generation of accurate results are likely to improve the adoption of
instruments over the coming years. For instance, in May 2021, the International
Society for Stem Cell Research updated guidelines for the development of
cell-based therapy and research. The proposed guidelines focus on all stages of
R&D and improve the quality of preclinical studies.
Technological
advancements in these devices are also broadening growth prospects of the
market. One of the promising technological advancements in differential cell
counting is the ability to recognize blasts, immunoplatelet counting, detection
of blasts, and reticulocyte fractions and stem cell counting with greater
accuracy. The advent of CD4+ T-cell counting technology has proven to be very useful
as an indicator of immune responses and has been adopted to evaluate the
success or failure of Anti-retroviral Therapy (ARV). Dedicated cytometers are
present in the market to perform CD4+ and CD8+ T-cell enumeration, such as the
FACSCount by Becton Dickinson is based on T-cell counting technology.
The
COVID-19 pandemic is anticipated to positively impact industry growth. WBC
count of the COVID-19 patient during admission is significantly correlated with
the death of patients. A higher level of white blood count should be given
further care in the COVID-19 treatment. The growing importance of cell count in
patients suffering from COVID-19 has augmented the growth of the industry
during the pandemic.
The
development of enhanced informatics solutions and improved image analysis
instruments such as optical or fluorescence microscopes have fueled the growth
prospects of this market. These instruments are being increasingly adopted in
low sample throughput laboratories and settings with limited resources, which
is highly prevalent in developing economies, thereby broadening the scope for
growth of the industry.
On
the other hand, limited availability of skilled professionals is the critical
growth-restraining factor of the market. The lack of skilled professionals can
be attributed to a lack of training facilities and high training costs. In
order to improve this scenario, industry players are required to participate in
the generation of training programs for software developed by these companies
and encourage healthcare professionals and researchers to operate cell counting
software. Moreover, the lack of standardization of these software tools also
plays a key role in restricting researchers and healthcare professionals as
every software differ in user interface.
List
of Key Players in Cell Counting Market
- Thermo Fisher
Scientific Inc.
- Merck KGaA
- Agilent
Technologies, Inc.
- PerkinElmer
- BD
- Danaher
Corporation
- Bio-Rad
Laboratories, Inc.
- GE HealthCare
- DeNovix
Request a free sample copy or view report
summary: Cell Counting Market Report
Cell
Counting Market Report Highlights
- By product,
consumables and accessories segment accounted for the largest revenue
share of 54.0% in 2024 and is expected to grow at the fastest CAGR of
during the forecast period
- The
microplates sub-segment is poised to expand at the fastest CAGR during the
forecast period. Microplates are usually used for analyzing very low
concentration samples. The increased consumption of these plates is
attributed to the repeated need to use fresh plates for analyzing a new
sample to prevent contamination
- In the
instruments segment, automated cell counters are anticipated to grow at an
exponential rate during the forecast period. Benefits such as short
testing time, reduced error occurrence, and inter-operator variability are
expected to further increase the demand for automated counters
- By
application, the complete blood count segment held the largest revenue
share of 59.4% in 2024. The large revenue share can be attributed to
increasing incidence of blood disorders
- In the
end-use segment, research and academic institutes accounted for the
largest revenue share of 39.8% in 2024 owing to growing number of
government initiatives focused on promoting R&D in various toxicology
studies
Cell
Counting Market Segmentation
Grand
View Research has segmented the global cell counting market report based on
product, application, end use, and region
Cell
Counting Product Outlook (Revenue, USD Million, 2018 - 2030)
- Instruments
- Spectrophotometers
- Flow
Cytometers
- Hemocytometer
- Automated
Cell Counters
- Microscopes
- Others
- Consumables
& Accessories
- Reagents
- Microplates
- Others
Cell
Counting Application Outlook (Revenue, USD Million, 2018 - 2030)
- Complete
Blood Count
- Automated
Cell Counters
- Manual Cell
Counters
- Stem Cell
Research
- Cell Based
Therapeutics
- Bioprocessing
- Toxicology
- Others
Cell
Counting End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
& Diagnostic Laboratories
- Research
& Academic Institutes
- Pharmaceutical
& Biotechnology Companies
- Others
Cell
Counting Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East
& Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
